Cellectis
Last updated: April 15, 2024
André Choulika, CEO and Founder
Country: France | Funding: $328.2M (+)
Website: http://www.cellectis.com/
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
Website: http://www.cellectis.com/
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.